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Abstract
Introduction: We sought to quantify changes in skeletal muscle
oxygenation during exercise using near-infrared spectroscopy
(NIRS) in healthy volunteers ascending to high altitude.
Methods: Using NIRS, skeletal muscle tissue oxygen saturation
(StO2) was measured in the vastus lateralis of 24 subjects.
Measurements were performed at sea level (SL; 75 m), at 3,500 m,
on arrival at 5,300 m (5,300 m-a; days 15 to 17) and at 5,300 m
again (5,300 m-b; days 69 to 71). Amongst the subjects, nine
remained at 5,300 m whilst 14 climbed to a maximum of 8,848 m.
Exercise was 3 minutes of unloaded cycling followed by an incre-
mental ramp protocol to exhaustion. The absolute StO2 at different
stages of exercise along with the difference between StO2 at
stages and the rate of change in StO2 were compared between
altitudes. Resting peripheral oxygen saturation was recorded.
Results: NIRS data achieving predefined quality criteria were
available for 18 subjects at 75 m, 16 subjects at 3,500 m, 16
subjects on arrival at 5,300 m and 16 subjects on departure from
5,300 m. At SL, mean StO2 declined from 74.4% at rest to 36.4%
at maximal oxygen consumption (P  <0.0001) and then rose to
82.3% (P  <0.0001) 60 seconds after exercise had ceased. At
3,500 m-a and 5,300 m-b, the pattern was similar to SL but
absolute values were approximately 15% lower at all stages. At
5,300 m-a, the resting StO2 was similar to SL and the change in
StO2 at each exercise stage less marked. At 5,300 m-b, the rate of
decline in StO2 during exercise was more rapid than SL (P = 0.008);
here the climbers had a smaller decline in StO2 during exercise
(41.0%) and a slower rate of desaturation (0.086%/second) than
those who had remained at 5,300 m (62.9% and 0.127%/second)
(P = 0.031 and P = 0.047, respectively).
Conclusion: In most individuals, NIRS can be used to measure
exercising skeletal muscle oxygenation in the field. During exercise
the patterns of absolute oxygenation are broadly similar at altitude
and SL. Following prolonged adaptation to altitude, the rate of
muscle desaturation is more rapid than observed at SL but less so
in those exposed to extreme hypoxia above 5,300 m.
Introduction
Interindividual tolerance to chronic hypoxaemia is highly
varied and may determine survival in the clinical context.
Specific mechanisms to explain this heterogeneous response
to a sustained reduction in systemic oxygen availability remain
unclear. Ascent to high altitude has been suggested as a
paradigm for studying human responses to hypoxia in order
to probe specific adaptive mechanisms pertinent to critical
illness [1]. In combination with exercise, this can provide an
effective method of manipulating the balance between
oxygen supply and utilisation. In skeletal muscle this equili-
brium of tissue oxygen metabolism governs exercise capacity,
whilst amongst other organs it is one of the primary deter-
minants of organ function.
The signal from near-infrared spectroscopy (NIRS) can be
used to estimate skeletal muscle microcirculatory oxygena-
tion, and principally reflects the venous haemoglobin oxygen
status [2,3]. Skeletal muscle oxygenation decreases during
exercise and the magnitude of this response is dependent on
exercise intensity [4-6]. This desaturation occurs despite an
increase in systemic oxygen flux, local vasodilatation leading
to enhanced regional blood flow, and increased tissue oxygen
extraction. The sustained reduction in exercise capacity,
measured by maximal oxygen consumption (VO2 max), at high
altitude is a highly reproducible phenomenon despite
adequate acclimatisation [7-10]. The precise mechanism of
this persistent decline in exercise capacity remains unclear,
but changes in oxygenation of the peripheral circulation
detectable by NIRS may help elucidate the phenomenon and
further our understanding of the adaptive mechanisms to
chronic hypoxaemia in the clinical environment.
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We hypothesised that, when measured at altitude, absolute
values of skeletal muscle tissue oxygen saturation (StO2)
measured by NIRS would be lower than those at sea level
(SL) both whilst resting and during exercise. We also hypo-
thesised that the difference in StO2 from rest to maximal
exercise would remain unchanged and the rate of desatura-
tion would increase at altitude. We therefore sought to
quantify the change in muscle oxygenation using NIRS during
exercise on ascent to high altitude.
Methods
Subject selection
Ethical approval for the present study was obtained from the
University College London Committee on the Ethics of Non-
NHS Human Research, and all participants gave written
informed consent. The subjects were 24 healthy volunteers
trekking to the base camp of Mount Everest (5,300 m) in spring
2007; six females and 18 males with a mean age of 35.2 years.
This group consisted of two predetermined cohorts. All shared
an identical ascent profile to 5,300 m; climbers (n = 14) then
ascended from 5,300 m to various altitudes, reaching a
maximum elevation of 8,848 m, whilst the base-camp team
(n = 10) remained at 5,300 m for the duration of the study.
Study settings
Baseline measurements of exercising skeletal muscle StO2
were performed at SL (75 m) before departure to high
altitude. Further measurements were taken at 3,500 m (days
4 to 6 of the expedition), on arrival at 5,300 m (5,300 m-a;
days 15 to 17) and before departure from 5,300 m
(5,300 m-b; days 69 to 71). Excessive exercise at altitude has
been associated with an increased risk of acute mountain
sickness [11]. Any subject suffering symptoms of acute
mountain sickness at altitude was therefore not studied.
Other exclusion criteria for cardiopulmonary exercise testing
were based on the American Thoracic Society/American
College of Chest Physicians guidelines for clinical exercise
testing [12]; all subjects with an absolute or relative
contraindication as defined by these guidelines were
excluded from exercise.
Measurement of skeletal muscle oxygenation
Measurements were made using the InSpectra™ Tissue
Spectrometer (Model 325; Hutchinson Technology Inc.,
Hutchinson, MN, USA) incorporating a 15 mm probe. The
spectrometer calculates StO2 by applying algorithms to the
NIRS signal reflected from tissue below the probe:
StO2 = (Oxygenated haemoglobin concentration / 
Total haemoglobin concentration) × 100
The spectrometer was connected to a laptop computer for
the storage of data during exercise. The NIRS probe was
placed on the skin of the dominant thigh over the lower third
of the vastus lateralis muscle, 10 cm proximal to the knee
joint. Once a signal had been confirmed on the spectrometer,
the probe was attached firmly with Elastoplast tape.
Measurements from the spectrometer were recorded during
the predetermined exercise protocol and 60 seconds into the
rest period that followed exercise. The InSpectra™ Tissue
Spectrometer recorded StO2 every 3 seconds during
standard data collection, and a time-point marker was
entered into the computer software to ensure synchronisation
of exercise and StO2 data.
Exercise protocol
The subjects performed an incremental ramp test to the limit of
tolerance using an electromagnetically braked cycle ergometer
(Lode Corival; Lode, Groningen, the Netherlands) and a breath-
by-breath cardiopulmonary exercise testing system (Metamax
3b; Cortex, Leipzig, Germany). A full calibration of the breath-
by-breath system was performed before each test. Prior to the
incremental exercise test, subjects warmed up with a low-
intensity 30-minute constant work rate protocol. A ramp slope
of 20 to 35 W/minute was chosen depending on the sex, age
and physical fitness of the subjects in order to obtain a test
duration of approximately 10 to 15 minutes [13]. The ramp
slope was kept constant for all subjects throughout the study.
Resting measurements were recorded for 3 minutes, followed
by 3 minutes of unloaded cycling (ULC) and then the
incremental ramped exercise protocol.
Measurement of peripheral oxygen saturation
Resting peripheral oxygen saturation (SpO2) was measured
using a pulse oximeter (Onyx 9500; Nonin, Plymouth, MN,
USA) on the subject’s right index finger.
Analysis plan
VO2 max was calculated as the average oxygen consumption
for the individual breaths taken in the final 20 seconds of the
exercise test. The time for VO2 max reported was the middle
time point of the 20-second time interval. Data were plotted
on graphs of StO2 versus time and were visually assessed
for quality and completeness. A number of NIRS plots were
rejected from analysis on the grounds that there was little or
no change in signal from rest throughout the exercise
protocol. These plots represented nonphysiological data,
and other authors have adopted a similar quality control
technique [14].
The resting StO2 was calculated as the average of readings
during a 30-second rest period before the exercise protocol
started. Individual subject StO2 at each principle stage of the
exercise protocol (end of 3 minutes ULC, VO2 max and
60 seconds after cessation of exercise) was calculated as the
average of three recordings (spanning 9 seconds) around the
designated time of occurrence. The mean (confidence
interval) of these StO2 values is reported for each altitude
along with differences between stage means (ΔStO2). The
rate of change in StO2 (StO2 rate) between the end of ULC
and VO2 max was calculated by dividing the difference in StO2
between stages by the time taken between stages.Two-tailed paired t tests were used to assess the affect of
altitude on StO2, ΔStO2 and StO2 rate. Comparison between
groups containing different individuals was by unpaired t test.
Correlation between the rate of decline in StO2 and SpO2
was by Pearson’s product-moment coefficient, and that
between StO2 and nonparametric data was with Spearman’s
rank correlation coefficient. P <0.05 was taken to indicate
statistical significance in all instances.
Results
Data collection and quality control
Data collection was incomplete due to a combination of
technical difficulties and subjects failing to fulfil the inclusion
criteria for exercise testing at altitude. All of the 24 subjects
completed the exercise protocol at SL; missing the exercise
protocol due to illness were two subjects at 3,500 m, one
subject at 5,300 m-a and two subjects at 5,300 m-b. NIRS
data were missing due to technical failure for four subjects at
SL, for two subjects at 3,500 m and for three subjects at
5,300 m-a. Three subjects (all female) were completely
removed from the analysis as part of the quality control
screening. NIRS data meeting the predefined quality criteria
were available for 18 subjects at SL, for 16 subjects at 3,500
m, for 16 subjects on arrival at 5,300 m and for 16 subjects
on departure from 5,300 m. Only six subjects had complete
data at each altitude time point, and their individual data can
be seen in Figure 1. The data presented are all of the
available data at each altitude time point.
Changes in absolute tissue oxygen saturation during
exercise
The mean StO2 at rest, at the end of ULC, at VO2 max and
60 seconds after VO2 max are presented in Table 1 for each
altitude along with the mean weight and resting SpO2. At SL,
the mean StO2 increased by 6.7% during ULC, from a resting
value of 74.4% (68.6 to 80.1) to 81.1% (73.8 to 88.3)
(P = 0.001). The mean StO2 progressively declined during
the incremental workload protocol to a nadir of 36.4% (28.5
to 44.3) at VO2 max (P <0.0001), and then rose rapidly to a
level above resting StO2 (82.3% (76.2 to 88.5); P <0.0001)
Available online http://ccforum.com/content/13/S5/S7
Page 3 of 9
(page number not for citation purposes)
Figure 1
Individual changes in tissue oxygen saturation during exercise. Individual changes in tissue oxygen saturation (StO2) during exercise in the subjects
with complete data at all altitude time points (n = 6). 5300m-a, on arrival at 5,300 m (days 15 to 17); 5300m-b, before departure from 5,300 m
(days 69 to 71); ULC, unloaded cycling; VO2 max, maximal oxygen consumption; 60sec-rest, 60 seconds after completion of exercise.60 seconds after exercise had ceased. At altitude the incre-
mental exercise protocol resulted in a reproducible pattern of
muscle desaturation. Figure 2 shows this pattern of change in
mean StO2 at SL and during ascent to altitude. At 3,500 m
and 5,300 m-b, the pattern was identical to SL but absolute
values were approximately 15% lower at all stages of the
exercise protocol. At 5,300 m-a, the resting StO2 was only
4.2% below that observed at SL (not significant) and the
pattern of change was considerably flatter than other
altitudes, such that the mean StO2 at VO2 max was 16.1%
higher than at SL (P = 0.043). Figures 3 and 4 show typical
NIRS plots (change in StO2 during exercise vs. time) from the
same subject at SL and at 5,300 m-b, respectively.
At 5,300 m-b there were no differences in the absolute StO2
values at any stage of exercise between climbers and the
base-camp team, although climbers had a significantly higher
SpO2 (86.6% vs. 79.2%, respectively; P = 0.005).
Tissue oxygen saturation differences between exercise
stages
The differences between mean StO2 values at different
stages of exercise at SL and at altitude are presented in
Table 2. There was no difference in ΔStO2 between rest and
VO2 max or between ULC and VO2 max at any altitude except
5,300 m-a, where the difference between rest and VO2 max
was 17.5%, compared with 38.0% at SL (P = 0.018).
At 5,300 m-b there was a significant difference in the ΔStO2
value between climbers and the base-camp team from ULC
to VO2 max; the base-camp team had a reduction of 62.9%,
compared with only 41.0% in the climbers (P = 0.031).
Time-related tissue oxygen saturation gradient and
subject rankings
StO2 gradients (StO2 rate values) between exercise stages at
each altitude are presented in Table 3. StO2 rate was increased
at 5,300 m-b compared with SL (P = 0.008) but not at the
other altitude time points.
At 5,300 m-b there was a significant difference in StO2 rate
between climbers and the base-camp team from ULC to
VO2 max; the base-camp team had a desaturation rate of
0.127%/second, compared with only 0.086%/second in the
climbers (P = 0.047).
Subjects were numerically ranked at each altitude based on
their rate of StO2 decline from the end of ULC to VO2 max.
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Table 1
Weight, SpO2 and StO2 during the exercise protocol at different altitude time points
Altitude
Sea level 3,500 m 5,300 m-a 5,300 m-b
Number of subjects 18 16 16 16
Weight (kg) 79.1 (72.7 to 85.5) 78.1 (71.2 to 85.1) 78.3* (71.9 to 84.6) 73.3* (69.0 to 77.6)
Resting SpO2 (%) 97.7 (97.2 to 98.2) 88.5* (86.8 to 90.2) 81.8* (79.8 to 82.8) 84.3* (81.4 to 87.2)
Resting StO2 (%) 74.4 (68.6 to 80.1) 58.4* (53.0 to 63.7) 70.2 (62.3 to 78.0) 57.5* (49.8 to 65.1)
StO2 3-minute ULC(%) 81.1† (73.8 to 88.3) 65.5*† (58.2 to 72.8) 80.3† (73.3 to 87.4) 69.7*† (63.4 to 76.0)
StO2 VO2 max (%) 36.4† (28.5 to 44.3) 24.8† (19.9 to 29.7) 52.5*† (41.7 to 63.3) 21.9† (12.0 to 31.7)
StO2 60 seconds post-exercise (%) 82.3† (76.2 to 88.5) 64.3*† (59.4 to 69.2) 69.8† (63.4 to 76.2) 63.1*† (54.8 to 71.4)
Data are presented as mean (95% confidence interval). SpO2, peripheral oxygen saturation; StO2, tissue oxygen saturation; ULC, unloaded
cycling; VO2 max, maximal oxygen consumption. *Significantly different from sea level. †Significantly different from the previous exercise stage.
Figure 2
Tissue oxygen saturation at specific stages of the work protocol. Mean
tissue oxygen saturation (StO2) at specific stages of the work protocol
at sea level and different altitude time points. 5300(a), on arrival at
5,300 m (days 15 to 17); 5300(b), before departure from 5,300 m
(days 69 to 71); Rest, resting; ULC, after 3 minutes of unloaded
cycling; VO2 max, at maximal oxygen consumption; Rec, 60 seconds
after exercise has ceased.Rankings were compared at each altitude by Spearman’s
rank correlation coefficient. There was a significant correla-
tion between the subject rank order at SL when compared
with 3,500 m (correlation coefficient = 0.780, P = 0.002),
compared with 5,300 m-a (correlation coefficient = 0.688,
P= 0.007) and compared with 5,300 m-b (correlation
coefficient = 0.41, P = 0.041).
Relationship between tissue oxygen saturation and
peripheral oxygen saturation
There was no correlation between the resting SpO2 and the
resting StO2 at any altitude. There was a correlation,
however, between resting SpO2 and StO2 at VO2 max at
5,300 m-b (r = 0.557,  P = 0.019). At 5,300 m-b there was
also a negative correlation between the resting SpO2 and
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Figure 3
Near-infrared spectroscopy plot at sea level. Typical near-infrared
spectroscopy plot from sea level (75 m). A, start of unloaded cycling;
B, start of loaded cycling; C, maximum oxygen consumption.
Figure 4
Near-infrared spectroscopy plot at altitude. Typical near-infrared
spectroscopy plot from 5,300 m-b (same subject as Figure 2). A, start
of unloaded cycling; B, start of loaded cycling; C, maximum oxygen
consumption.
Table 2
Change in StO2 between specific stages of the exercise protocol at different altitude time points
Altitude
Difference Sea level 3,500 m 5,300 m-a 5,300 m-b
Rest – VO2 max (%) 38.0 (27.9 to 48.1) 33.6 (26.6 to 40.6) 17.7* (10.0 to 25.3) 35.6 (24.4 to 46.8)
3 minutes ULC – VO2 max (%) 44.7 (34.2 to 55.2) 40.7 (32.2 to 49.2) 27.8 (20.2 to 35.4) 47.8 (37.5 to 58.2)
Data are presented as mean (95% confidence interval). StO2, tissue oxygen saturation; ULC, unloaded cycling; VO2 max, maximal oxygen
consumption. *Significantly different from sea level.
Table 3
StO2 decline between unloaded cycling and VO2 max during exercise at different altitude time points
Altitude
Sea level 3,500 m 5,300 m-a 5,300 m-b
StO2 rate from ULC to VO2 max 0.063 (0.047 to 0.080) 0.067 (0.050 to 0.083) 0.056 (0.041 to 0.072) 0.099 (0.078 to 0.120)*
(%/second)
Data are presented as mean (95% confidence interval). StO2, tissue oxygen saturation; ULC, unloaded cycling; VO2 max, maximal oxygen
consumption. *Significantly different from sea level (P <0.05).StO2 rate (r = –0.562, P = 0.023), such that those individuals




The present study demonstrated in selected individuals that
NIRS could be used to measure skeletal muscle StO2 in the
vastus lateralis during exhaustive exercise and to generate
reproducible results in the hypoxic environment encountered
at high altitude. Three minutes of unloaded exercise at SL led
to a small rise in StO2 that progressively declined as the
exercise workload increased. StO2 reached a plateau shortly
before VO2 max was achieved, and then, following cessation of
exercise, rapidly recovered to a level above the resting value.
Figures 3 and 4 show typical examples of the change in StO2
during unloaded and loaded exercise at different altitudes. At
3,500 m, the absolute changes in StO2 were similar to those
at SL but values were approximately 15% lower at rest and
throughout exercise. On arrival at higher altitude (5,300 m-a),
the resting StO2 was similar to that at SL and the changes
during exercise (ΔStO2 values) were considerably less
marked than those observed at SL, giving the appearance of
a flattened pattern of StO2 (Figures 1 and 2). By the end of
the expedition (5,300 m-b), days 69 to 71 at altitude, the
pattern was similar to that observed at SL and at 3,500 m
(that is, ΔStO2 unchanged) except that the time-related
decline in StO2 (StO2 rate) during exercise was significantly
more rapid than that at SL (P = 0.008).
At altitude, the maximum exercise capacity was reduced –
leading to a reduction in VO2 max as has been previously
documented [7-10,15] – and the decline in VO2 max was
proportional to elevation.
Study limitations
There were marked interindividual differences in absolute
StO2 values at rest and during exercise (Table 1). One
reason for these differences is related to the fact that near-
infrared light emitted by and received by the spectrometer
probe has an unknown pathlength, and therefore the absolute
StO2 cannot be calculated [16]. Furthermore, significant
heterogeneity in oxygenation has been demonstrated both
within and between specific muscles so probe placement on
the thigh is important and may have a significant effect upon
results [17-19]. StO2 is therefore a value that is specific to
the tissue beneath an individual probe. As a result of this,
comparison of absolute StO2 values between individuals is of
limited value. The relative changes in StO2 as a result of
specific stimuli (ΔStO2), and the rate of change in the
response (StO2 rate), however, may provide valuable insight
into the dynamics of oxygen supply and demand in a subject.
The depth of tissue beneath the spectrometer probe that
near-infrared light can penetrate is directly related to the
distance between the illumination and detection fibres
(optodes) of the device. The banana-shaped light beam has a
maximum depth of approximately one-half the distance
between the optodes [20]. The InSpectra™ Tissue
Spectrometer was fitted with a 15 mm probe, which means
the maximum depth of penetration was approximately
7.5 mm. For some individuals this may not represent muscle
tissue oxygenation but overlying adipose tissue or skin. This
factor may further increase the interindividual variation in the
NIRS signal. Most of the NIRS plots that were rejected as a
result of minimal change in oxygenation throughout exercise
were from females; this has been previously noted as a
substantial confounding factor during skeletal muscle NIRS
studies [21]. Other authors also report needing to remove
subjects from the final analysis as a result of poor signal
response due to excessive subcutaneous adipose tissue
[14]. Validated objective criteria for rejection of
nonphysiological NIRS data do not exist. Subjective removal
of data may therefore confound results; however, data
removal was performed without the knowledge of the subject
or altitude identification.
As the NIRS light beam must pass through skin during both
emission and reflection, skin blood flow and oxygenation will
contribute to the overall NIRS signal [22,23]. Ambient
laboratory temperature may therefore have exerted an effect
on results by inducing vasoconstriction within the skin at low
temperature. All studies were performed in purpose-built
insulated temporary laboratories where the average
temperature throughout the 3-month expedition was 24.1°C
at SL, 19.6°C at 3,500 m and 21.5°C at 5,300 m. Diurnal
temperature variation may have resulted in temperatures
considerably lower than these mean values for those tests
performed early in the morning at altitude. The preliminary
warm-up exercise protocol, however, should have provided
sufficient stimulus to negate the effect of cold-induced
vasoconstriction.
Interpretation of results
Although a rarely regarded tissue in the critically ill patient,
early reduction in skeletal muscle StO2 detected by NIRS has
been shown to herald poor outcome by identifying patients at
risk of infectious complications or multiple organ failure [24].
Rather than a quantitative measurement of tissue oxygena-
tion, however, the StO2 value derived from a NIRS signal
reflects the localised equilibrium of oxygen delivery and
utilisation [25] and closely follows regional venous oxygena-
tion [14,26]. Furthermore, correlation between changes in the
continuous-wave NIRS signal and that of 31P magnetic
resonance spectroscopy [25] and of 1H nuclear magnetic
resonance [27] suggests that NIRS can be used effectively in
the evaluation of localised muscle oxidation. As a measure of
oxygen saturation, StO2 could be regarded as a surrogate
marker for tissue oxygen content, therefore indicating crude
alterations in tissue oxygen extraction. Previous work has
demonstrated that acute exposure to hypoxia results in a
Critical Care    Vol 13 Suppl 5 Martin et al.
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exercise when compared with normoxia [28].
The change in absolute StO2 observed in the present study
at SL has been previously reported by other authors at SL;
typically, there is an initial increase in oxygenation followed by
a decline until the minimum plateau value at VO2 max
[4,14,29]. The commonly observed plateau of StO2 shortly
before VO2 max at SL (Figure 3) tended not to be as prominent
at 5,300 m-b (Figure 4), although this was difficult to quantify.
The significance of this plateau has been suggested as
representing the limit of tissue oxygen extraction [14,28]. The
relationship between maximal oxygen extraction and VO2 max
may therefore be altered after prolonged exposure to hypoxia
and requires more detailed investigation. Similar values for
ΔStO2 at SL, 3,500 m and 5,300 m-b suggest that the overall
balance between oxygen delivery and utilisation at these
altitude time points were similar. Oxygen delivery exceeded
utilisation during ULC, resulting in an increase in StO2 – but
as the work rate increased the situation was reversed, until
the peri-VO2 max plateau when oxygen extraction was maximal
and exhaustion was imminent.
The relatively high resting StO2 and reduced ΔStO2 between
rest and VO2 max observed at 5,300 m-a (Figures 1 and 2) is
not in keeping with the findings at 3,500 m and 5,300 m-b.
Identical equipment, protocols and investigators were used
on arrival at and departure from 5,300 m, so technical failure
or inaccuracy seems unlikely. Limited ability to extract oxygen
could account for the reduced ΔStO2 value; however, the
reason for this on arrival at 5,300 m is unclear. One hypothe-
sis is that the small gain in weight observed from 3,500 m to
5,300 m may represent a degree of tissue oedema that could
increase oxygen diffusion limitation in muscle tissue. The
usual response of ascent to altitude is generally weight loss
[30]; the gain in weight observed, or certainly the lack of loss,
could therefore be tissue fluid accumulation, frequently
observed in those affected detrimentally by high altitude [31].
The rate of decline in StO2 during loaded exercise (end of
ULC to VO2 max), as presented in Table 3, is significantly more
rapid at 5,300 m-b than at SL. This more rapid rate of decline
was not seen on arrival at the same altitude 50 days previous
to the departure measurements despite the small rise in mean
SpO2 at 5,300 m-b (P = 0.002). Weight loss at altitude
results in a greater proportion of lean tissue mass than fat
mass [30], which leads to a reduction in the skeletal muscle
fibre cross-sectional area [32]. In the group investigated in
the present study, mean weight loss during the expedition
was 5.8 kg in 72 days (P <0.001).
At 5,300 m-b, those subjects with a lower resting SpO2
showed a more rapid rate of StO2 desaturation during
exercise. One explanation for this could be that individuals
with a low SpO2 at rest had reduced systemic oxygen
availability due either to a blunted hypoxic ventilatory
response or to an increased arterial–alveolar oxygen partial
pressure difference. Following acclimatisation to high altitude,
however, cardiac output remains unchanged from SL values
for a given work load throughout exercise [9,33], and the
arterial oxygen content remains above SL values [34,35] even
at maximal exercise [36]. This implies that systemic oxygen
delivery remains similar to that experienced at SL under
conditions similar to those experienced by the subjects in this
study. More distal mechanisms in the oxygen cascade – such
as alterations in regional and/or microcirculatory blood flow,
changes in the affinity of oxygen to haemoglobin or diffusion
limitation within skeletal muscle tissue – may therefore be
responsible for the observed findings.
At the end of the expedition (5,300 m-b) the base-camp team
who remained at 5,300 m after ascent were found to have a
significantly greater ΔStO2 and StO2 rate of decline during
exercise than the climbers who ascended above 5,300 m. In
the climbing cohort, the exposure to severe hypoxia at
altitudes up to 8,848 m is likely to have induced a greater rise
in haemoglobin than the base-camp team, thus increasing
arterial oxygen content and preventing such a precipitous fall
in skeletal muscle oxygenation during exercise. Alternatively,
exposure to such hypoxic conditions may trigger a process of
hypoxic preconditioning that affords a degree of protection
following descent to lower heights.
In the clinical setting, abnormal heterogeneous blood flow in
the sublingual microcirculation of critically ill patients [37-39]
may account for the imbalance between oxygen delivery and
consumption in this pathological state [40]. Reduced sub-
lingual microcirculatory blood flow has been observed in
climbers ascending to high altitude [41]. If abnormal blood
flow also exists in skeletal muscle microvasculature, one
could postulate that it may lead to a reduction in tissue
oxygen delivery and hence in StO2.
Conclusion
NIRS is a useful tool for studying thigh skeletal muscle
oxygenation during exercise but is limited by the depth of
beam penetration in some individuals. The pattern of absolute
change in exercising muscle StO2 on exposure to altitude is
similar to that at SL and, despite the reduction in exercise
capacity, demonstrates a similar reduction in StO2 from rest
to maximal exertion. The rate of desaturation is more rapid
after prolonged exposure to altitude (69 to 71 days), and at
this altitude time point a lower resting SpO2 was associated
with a more rapid rate of StO2 decline during exercise.
Exposure to extreme hypoxia above 5,300 m appears to have
a protective effect in reducing the degree of muscle
desaturation during exercise on return to 5,300 m.
These findings suggest that mechanisms within the peripheral
circulation or tissues govern local tissue oxygen flux and
utilisation. Alterations at the distal portion of the oxygen
cascade may be an important component of adaptation or
maladaptation to chronic hypoxia secondary to high altitude
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responses to chronic hypoxia may therefore be explained by
changes in the peripheral circulation rather than the systemic
circulation in both scenarios.
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